Biomedical interventions for HIV prevention in MSM in Amsterdam: a demonstration project

Academic Medical Center0 个研究点开始时间: 2015年4月29日最近更新: 2015年7月10日

适应症

试验速览

暂无简介。

•1.Male or transgender, age 18 years or more
•3.Completed HIV and STI screening
•4.HIV negative by 4th generation Elisa antigen/antibody test.
•5.Willing and able to comply to project visit schedule and procedures
•6.Willing and able to give written informed consent
•7.Sufficient understanding of Dutch or English
•AND at least one of the following:
•1.One or more documented STI (urethral or anal chlamydia or gonorrhoea, primary or secondary syphilis) in the last 6 months (either at STI clinic or a documented infection diagnosed elsewhere)
•2.UAI with casual partners in the last 6 months
•3.Received PEP after sexual risk incident in the last 6 months
•4.HIV positive partner with unknown or detectable viral load
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 350
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 20

•1.Signs or symptoms of acute HIV infection1
•2.Hepatitis B infection (i.e. HbsAg positive)
•3.Creatinine clearing (using cockroft gault formula) < 60 ml/min
•4.Hypersensitivity for one of the components of fixed combination tablet containing tenofovir and emtricitabine
•5.Unlikely, in the opinion of the clinician, to comply with trial schedule

发起方

Academic Medical Center